#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia beta Small for dates baby Brain stem glioma Malignant melanoma Obesity Pseudomyxoma peritonei Friedreich's ataxia Plasma cell myeloma Choroidal dystrophy Neurotrophic keratopathy Pulmonary hypertension Osteomyelitis Leiomyosarcoma recurrent Solitary fibrous tumour Immune thrombocytopenia More trials…

    Learn about Rare Diseases

    Alexander disease – Treatment Gastrointestinal stromal tumour – Diagnostics Short-bowel syndrome – Diagnostics Myxofibrosarcoma – Life with Disease Turner’s syndrome – Diagnostics Nodal marginal zone B-cell lymphoma – Basic Information CADASIL – Life with Disease Mucopolysaccharidosis II – Diagnostics Haemophilia – Life with Disease Osteosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VERTEPORFIN Famotidine Gindameran Mps-200 Cefotaxime CAMOSTAT MESILATE 13N-AMMONIA Rosuvastatin Zinc Pf-07220060 Monohydrate Giroctocogene Fitelparvovec Jnj-77242113 Vobramitamab Duocarmazine Vismodegib Vatiquinone Dopamine Hydrochloride Neomycin Sulfate Iohexol Pervi-Neo Phenylalanine Db-Oto-3 More therapies…

    Learn about Your Condition

    Immunosuppression Medullary thyroid cancer Castleman's disease Acromegaly Sepsis Paget's disease of the vulva Anal fistula Ischaemic skin ulcer Embolic stroke Myocardial infarction Medication overuse headache Noninfective chorioretinitis Pyelonephritis Hairy cell leukaemia Somatic symptom disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colon cancer stage II

  • Study on the Effects of Imipramine in Patients with Colon, Rectal, or Breast Cancer Over-Expressing Fascin1

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    • Rectal cancer
    Investigated Drugs:
    • Imipramine Hydrochloride
    Spain

  • Study on Post-Surgery Treatment for Colon Cancer Patients Using Trifluridine, Irinotecan, and Drug Combination

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated Drugs:
    • Trifluridine
    • Tucatinib
    • Irinotecan
    Italy

  • Study on the Effect of Intensive Chemotherapy with FOLFOXIRI Compared to Standard Treatment for Patients with Localized Colon Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    Spain

  • Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Rectal cancer stage II
    Investigated Drugs:
    • Capecitabine
    Austria Germany

  • Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Stage II and III Colon Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Placebo
    The Netherlands

  • Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Placebo
    Belgium
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!